CVS files Form 144 to sell 32,000 shares

CVS submitted a Form 144 notice reporting an intended sale of 32,000 shares of Common Stock in connection with compensation, with the sale date shown as 11/20/2025.

Rhea-AI Filing Summary

CVS submitted a Form 144 notice reporting an intended sale of 32,000 shares of Common Stock in connection with compensation, with the sale date shown as 11/20/2025. The filing lists brokers and numeric entries including 05/20/2026.

Key Figures

Shares proposed for sale: 32,000 shares Securities information date: 05/20/2026 Numeric entry 1: 214,283.47 +1 more

4 metrics

Shares proposed for sale 32,000 shares Securities To Be Sold; sale date <date>11/20/2025</date>

Securities information date 05/20/2026 Date appearing in the securities information rows

Numeric entry 1 214,283.47 Listed in securities information row alongside TD Securities (USA) LLC

Numeric entry 2 2,815,796.53 Listed in securities information row alongside KeyBanc Capital Markets

Key Terms

Form 144, Compensation, Issuer

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Compensation financial

"Common | 11/20/2025 | Compensation | Issuer"

Issuer regulatory

"Common | 11/20/2025 | Compensation | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CVS's Form 144 filing mean for shareholders?

It notifies the SEC of a proposed sale of 32,000 shares tied to compensation, dated 11/20/2025. The form is an administrative notice required for certain restricted or control stock sales and does not itself execute a sale.

When is the proposed sale date listed on CVS's Form 144?

The form lists 11/20/2025 as the sale date for the 32,000-share compensation-related transaction. The filing also shows the entry 05/20/2026 in the securities information rows.

Who are the brokers named in the CVS Form 144 filing?

The filing lists TD Securities (USA) LLC and KeyBanc Capital Markets with addresses in New York and Cleveland. These broker-dealers appear in the securities information section of the notice.

Does the Form 144 show proceeds or price for the CVS shares?

The excerpt includes numeric amounts (214,283.47 and 2,815,796.53) in the securities information rows, but it does not explicitly label them as sale proceeds or per-share prices in the provided excerpt.

Is a Form 144 the same as an executed sale?

No. A Form 144 is a notice of a proposed sale by an affiliate or person holding restricted securities. It does not confirm that a sale has occurred; it registers intent under the applicable rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 05:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001224983
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CVS Health Corporation
SEC File Number	001-01011
Address of Issuer	One CVS Drive Woonsocket RHODE ISLAND 02895
Phone	4017651500
Name of Person for Whose Account the Securities are To Be Sold	AGUIRRE FERNANDO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	TD Securities (USA) LLC 125 Park Avenue 20th Floor New York NY 10017	2263	214283.47	1275927307	05/20/2026	NYSE
Common	KeyBanc Capital Markets 127 Public Square Cleveland OH 44114	29737	2815796.53	1275927307	05/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Compensation	Issuer			32000	11/20/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	These shares are being sold for Fernando Aguirre. The shares were acquired across various dates from 11/28/2018 through 11/20/2025. This form is being filed late due to broker error.
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Fernando Aguirre
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)